Process Development & Manufacturing

Sophia CDMO provides integrated process development and GMP manufacturing services for biologics programs from early development through commercial readiness. Our teams align upstream, downstream, analytics, and quality to reduce handoffs, accelerate timelines, and build scalable, well-controlled processes. We focus on predictable execution, phase-appropriate rigor, and transparent program governance so sponsors can make confident CMC decisions with minimal rework.

Overview of Services

Sophia CDMO supports the full process lifecycle:

Process concept development for early-stage programs
Process optimization and scale-up for clinical supply and late-stage readiness
Tech transfer from sponsor sites, academic labs, or other CDMOs
GMP manufacturing for clinical and (as applicable) commercial supply
Process characterization and validation readiness aligned to program stage
Continuous improvement and change management support across the lifecycle

Engagements can be structured as a fully integrated program or as modular services (e.g., upstream optimization only, downstream troubleshooting, engineering batches, GMP clinical manufacturing).

Process Development Approach

Sophia CDMO applies a structured, risk-based development approach designed to deliver robust performance and clear control strategies.

Phase-Appropriate Development

We tailor the development plan to program stage:

Early phase (Feasibility / IND-enabling): rapid iteration, fit-for-purpose methods, and manufacturability screening
Mid phase (Phase II/III): improved robustness, defined operating ranges, enhanced control strategies, and comparability readiness
Late phase (Commercial readiness): characterization planning, validation-aligned documentation, and lifecycle control planning

This approach reduces over-investment early while preventing late-stage surprises.

Risk-Based Planning and Decision Gates

Each program begins with an assessment and a risk register that typically covers:

Product quality risks (known/anticipated CQAs, degradation pathways, heterogeneity drivers)
Process performance risks (yield, impurity clearance, robustness)
Scale-up risks (mixing, oxygen transfer, shear, hold times)
Material and supply risks (raw materials, resins, filters, lead times)
Analytical readiness risks (method suitability, transfer status, reference materials)

We translate these risks into an execution plan with defined decision gates, acceptance criteria, and clear deliverables.

Upstream Process Development

Sophia CDMO develops upstream processes designed for productivity, consistency, and scalability.

Core Upstream Capabilities

Cell culture process design and optimization
Media and feed strategy development
Parameter screening and optimization using risk-based experimental designs
Scale-down model development and qualification (as appropriate)
In-process control strategy development
Raw material evaluation and risk assessment
Process troubleshooting and performance recovery

Outcomes Sponsors Typically Seek

Improved titer and consistent growth profiles
Stable performance across lots and manufacturing campaigns
Reduced variability through defined parameter ranges
A practical in-process monitoring plan that supports real-time decision-making

Where platform approaches are appropriate, we use them to accelerate development. For non-standard molecules or challenging cell culture behavior, we build a tailored strategy grounded in data and risk control.

Downstream Process Development

Sophia CDMO designs and optimizes downstream processes for yield, impurity clearance, and consistent product quality.

Core Downstream Capabilities

Purification train design (capture, intermediate, polishing)
Chromatography and filtration optimization (resins, membranes, loading strategies)
Viral inactivation/filtration strategy development (as applicable)
Impurity clearance development (HCP, DNA, aggregates, process-related impurities)
UF/DF development (concentration, diafiltration strategy, buffer exchange)
Hold-time evaluation and process robustness assessments
Troubleshooting for difficult impurity profiles and yield losses

Process Design Priorities

High and consistent step recoveries
Defined impurity clearance performance with appropriate monitoring
Control of aggregation and variants through condition selection
Scalable operations that translate reliably into GMP manufacturing

Downstream work is tightly integrated with analytics so purification decisions are supported by clear product quality data.

Process Characterization and Validation Readiness

Sophia CDMO supports process characterization and validation readiness in a phase-appropriate manner.

Characterization Support (As Applicable)

Identification of critical process parameters (CPPs) and parameter impact studies
Definition of operating ranges and robust setpoints
Hold-time and intermediate stability studies
Evaluation of scale effects and comparability planning
Risk-based control strategy refinement

Validation Readiness Planning

For programs approaching PPQ or commercial readiness, Sophia CDMO supports:

Validation-aligned development documentation
Process performance strategy inputs
Control strategy traceability and lifecycle considerations
Alignment between manufacturing execution, analytics, and quality oversight

We focus on building a defensible process story where development data, manufacturing outcomes, and control strategies are consistent and traceable.

GMP Manufacturing

Sophia CDMO provides GMP manufacturing execution for clinical programs and commercial readiness planning where applicable. Our manufacturing operations emphasize right-first-time documentation, robust quality oversight, and predictable scheduling.

Manufacturing Services

Clinical manufacturing campaigns
Engineering and demonstration batches (as applicable)
GMP batch execution and in-process monitoring
Batch record authoring inputs and execution support
Deviation management, investigations, and CAPA coordination
Manufacturing trend reporting and continuous improvement support

Manufacturing Philosophy

Build manufacturability into development decisions early
Execute with disciplined adherence to defined processes and documentation practices
Maintain transparent sponsor communication during execution
Drive investigations to root cause and corrective action—not superficial closure

Sophia CDMO supports sponsor oversight expectations with clear governance, timely updates, and structured batch documentation packages.

Tech Transfer and Scale-Up

Sophia CDMO treats tech transfer as a structured risk-reduction activity designed to protect product quality and prevent timeline disruption.

Tech Transfer Framework

Technical gap assessment (process, analytics, materials, documentation)
Transfer plan with roles, deliverables, and acceptance criteria
Scale-down model alignment and bridging strategy
Engineering runs and process familiarization (as needed)
GMP readiness review before batch execution

Scale-Up Support

We support scale-up planning focused on:

Mixing, mass transfer, and shear sensitivity considerations
Holding and intermediate stability risks
Material equivalency and sourcing constraints
Process parameter translation and monitoring strategy
Comparability planning for changes introduced during scale transition

We aim to ensure that scale-up is predictable and supported by data, not trial-and-error.

Manufacturing Support Functions

Materials and Supply Planning

Sophia CDMO supports supply planning aligned to manufacturing schedules, including:

Raw material risk evaluation and lead-time planning
Resin and filter strategy coordination
Lot traceability and documentation support
Cold chain and shipment coordination support (as applicable)

Operational Excellence

Our operations emphasize:

Standardized execution practices
Defined escalation pathways and governance cadence
On-time delivery of documentation and data packages
Continuous improvement based on performance trending

Integration With Analytics and Quality

Sophia CDMO’s process development and manufacturing model is closely integrated with analytical and quality teams to maintain a consistent data story.

Integration benefits include:

Faster troubleshooting via aligned sampling and testing strategies
Improved comparability readiness for process changes and scale transitions
Clear control strategy alignment between manufacturing and release testing
Stronger documentation packages for sponsor audits and regulatory submissions

This integration reduces rework, improves predictability, and supports faster decision-making.

Typical Deliverables

Depending on scope and stage, Sophia CDMO deliverables may include:

Process descriptions and development reports
Tech transfer packages and risk assessments
Batch documentation packages and executed records
Investigation reports and CAPA documentation (as needed)
Manufacturing summaries and trend reports
Characterization and robustness study summaries
Inputs for CMC documentation and regulatory submissions

Deliverables are designed to be sponsor-ready: clear, complete, and traceable.

How Sophia CDMO Supports Faster Timelines

Sophia CDMO accelerates timelines through:

Early risk identification and clear decision gates
Integrated project plans across development, analytics, manufacturing, and quality
Efficient tech transfer and readiness reviews
Focused experimentation and data-driven parameter setting
Transparent governance and rapid escalation pathways

We prioritize the work that unlocks the critical path while maintaining compliance and product quality.

Engagement Models

Sophia CDMO supports multiple engagement structures:

End-to-end development and manufacturing programs
Standalone upstream or downstream development
Process troubleshooting and remediation projects
Tech transfer and scale-up-only engagements
GMP manufacturing campaigns with defined supply milestones

We align scope and governance to your internal capabilities and program goals.